Company: DVAX
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001029142-25-000117
Chunk: 249

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 1
Chunk 249
---
24$ % HEPLISAV-B$91,872 $70,188 $21,684 31%$156,831 $118,032 $38,799 33%Total product revenue, net91,872 70,188 21,684 31%156,831 118,032 38,799 33%Other revenue3,570 3,607 (37)(1%)6,775 6,552 223 3 %Total revenues$95,442 $73,795 $21,647 29%$163,606 $124,584 $39,022 31%

(1) Other revenue primarily includes revenue from our agreement with the DoD.

HEPLISAV-B product revenue increased by $21.7 million and $38.8 million for the three and six months ended June 30, 2025, respectively, compared to the same periods in 2024. 

For the three and six months ended June 30, 2025, respectively, approximately $8.2 million and $17.2 million of the increase in product revenue was due to higher volume, largely driven by continued improvement in market share, and growth in the U.S. hepatitis-B vaccine market. Increases in net sales price contributed approximately $9.1 million and $14.0 million for the three and six months ended June 30, 2025, respectively, compared to the same periods in 2024. Adjustments to our returns reserve estimate contributed approximately $3.5 million and $6.8 million for the three and six months ended June 30, 2025, respectively, compared to the same periods in 2024, driven by lower observed HEPLISAV-B product return rates.

Additionally, HEPLISAV-B product revenue, net included approximately $1.6 million related to non-U.S. sales for each of the three and six months ended June 30, 2025, compared to approximately $1.2 million and $2.3 million related to non-U.S. sales for the three and six months ended June 30, 2024, respectively. We do not currently anticipate revenue from non-U.S. sales in the near future.

Cost of Sales – Product

Cost of sales - product consists primarily of raw materials, certain fill, finish and overhead costs and any inventory adjustment charges for HEPLISAV-B. 

31

The following is a summary of